2-Aminopyrimidine derivatives as raf kinase inhibitors
申请人:Batt Bryant David
公开号:US20060293340A1
公开(公告)日:2006-12-28
This application discloses compounds that inhibit Raf kinase having the formula (I), wherein R
1
is a phenyl radical or a heteroaryl radical; and R
2
is a phenyl radical; or an N-oxide or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of proliferative diseases, such as cancer.
2-AMINOPYRIMIDINE DERIVATIVES AS RAF KINASE INHIBITORS
申请人:Novartis AG
公开号:EP1635835B1
公开(公告)日:2010-01-06
[EN] 2-AMINOPYRIMIDINE DERIVATIVES AS RAF KINASE INHIBITORS<br/>[FR] DERIVES DE 2-AMINOPYRIMIDINE UTILISES COMME INHIBITEURS DE RAF KINASE
申请人:NOVARTIS AG
公开号:WO2004110452A1
公开(公告)日:2004-12-23
This application discloses compounds that inhibit Raf kinase having the formula (I), wherein R1 is a phenyl radical or a heteroaryl radical; and R2 is a phenyl radical; or an N-oxide or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of proliferative diseases, such as cancer.